Abstract:Background: Skeletal Stem Cells (SSCs) are required for skeletal development, homeostasis, and repair. The perspective of their wide application in regenerative medicine approaches has supported research in this field, even though so far results in the clinic have not reached expectations, possibly due also to partial knowledge of intrinsic, potentially actionable SSC regulatory factors. Among them, the pleiotropic cytokine RANKL, with essential roles also in bone biology, is a candidate deserving deep investigation. Methods: To dissect the role of the RANKL cytokine in SSC biology, we performed ex vivo characterization of SSCs and downstream progenitors (SSPCs) in mice lacking Rankl (Rankl-/-) by means of cytofluorimetric sorting and analysis of SSC populations from different skeletal compartments, gene expression analysis, and in vitro osteogenic differentiation. In addition, we assessed the effect of the pharmacological treatment with the anti-RANKL blocking antibody Denosumab (approved for therapy in patients with pathological bone loss) on the osteogenic potential of bone marrow-derived stromal cells from human healthy subjects (hBMSCs). Results: We found that, regardless of the ossification type of bone, osteochondral SSCs had a higher frequency and impaired differentiation along the osteochondrogenic lineage in Rankl-/- mice as compared to wild-type. Rankl-/- mice also had increased frequency of committed osteochondrogenic and adipogenic progenitor cells deriving from perivascular SSCs. These changes were not due to the peculiar bone phenotype of increased density caused by lack of osteoclast resorption (defined osteopetrosis); indeed, they were not found in another osteopetrotic mouse model, i.e., the oc/oc mouse, and were therefore not due to osteopetrosis per se. In addition, Rankl-/- SSCs and primary osteoblasts showed reduced mineralization capacity. Of note, hBMSCs treated in vitro with Denosumab had reduced osteogenic capacity compared to control cultures. Conclusions: We provide for the first time the characterization of SSPCs from mouse models of severe recessive osteopetrosis. We demonstrate that Rankl genetic deficiency in murine SSCs and functional blockade in hBMSCs reduce their osteogenic potential. Therefore, we propose that RANKL is an important regulatory factor of SSC features with translational relevance.

RBPjκ-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development

Notch Signaling Maintains Bone Marrow Mesenchymal Progenitors by Suppressing Osteoblast Differentiation

Stage-specific Effects of Notch Activation During Skeletal Myogenesis

Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling

Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation

Dnmt3b ablation impairs fracture repair through upregulation of Notch pathway

The role of notch 1 activation in cardiosphere derived cell differentiation.

The Role ofNotch 1Activation in Cardiosphere Derived Cell Differentiation

Notch signaling negatively regulates BMP9-induced osteogenic differentiation of mesenchymal progenitor cells by inhibiting JunB expression.

Notch-Rbp-J Signaling Regulates The Mobilization And Function Of Endothelial Progenitor Cells By Dynamic Modulation Of Cxcr4 Expression In Mice

Disruption of the transcription factor RBP-J results in osteopenia attributable to attenuated osteoclast differentiation

NOTCH1 Regulates Osteoclastogenesis Directly in Osteoclast Precursors and Indirectly Via Osteoblast Lineage Cells*

Functional Notch Signaling is Required for Bmp4-Induced Inhibition of Myogenic Differentiation

A Comprehensive Analysis of the Dual Roles of BMPs in Regulating Adipogenic and Osteogenic Differentiation of Mesenchymal Progenitor Cells

Shp2 Regulates Intramembranous Ossification By Modifying The Tgf Beta And Bmp2 Signaling Pathway

Notch Signaling in Osteocytes Differentially Regulates Cancellous and Cortical Bone Remodeling

Rankl genetic deficiency and functional blockade undermine skeletal stem and progenitor cell differentiation

Prrx1-driven LINC complex disruption in vivo reduces osteoid deposition but not bone quality after voluntary wheel running

Rbpj, the Transcription Factor Downstream of Notch Receptors, is Essential for the Maintenance of Vascular Homeostasis in Adult Mice

c-Jun N-Terminal Kinases (JNKs) Are Critical Mediators of Osteoblast Activity In Vivo.

Biphasic Regulation of Osteoblast Development Via the ERK MAPK–mTOR Pathway